Why the study?
Calcification leading to bovine pericardial valve conduit failure is affected by biomaterial chemical composition, but structural differences between diepoxy-treated and glutaraldehyde-treated conduits remained to be compared.
Does diepoxy treatment of bovine pericardial conduits reduce calcification compared to glutaraldehyde treatment in a minipig model of pulmonary artery replacement?
Does diepoxy treatment of bovine pericardial conduits reduce calcification compared to glutaraldehyde treatment in a minipig model of pulmonary artery replacement?
Diepoxy treatment of bovine pericardial conduits prevents collagen mineralization and improves tissue integration compared to glutaraldehyde treatment in a large animal model, suggesting potential benefits for pediatric RVOT reconstruction.
Answers are grounded in this paper and cite their sources.
Does not support clinical adoption of diepoxy-treated conduits; leaves open translation to pediatric RVOT reconstruction pending human trials.
Background/Objectives: Bovine pericardial valve conduits (PVCs) are commonly used for right ventricular outflow tract reconstruction in both pediatric and adult patients. Calcification, particularly prevalent in children and young adults, is a leading cause of conduit failure and is affected by the chemical composition of the treated biomaterials. In this study, we aimed to compare the structural changes in diepoxy-treated (DE-PVCs) and glutaraldehyde-treated PVCs (GA-PVCs) and to identify factors contributing to tissue mineralization in a large animal model. Methods: Pulmonary artery replacement was performed in minipigs (33–88 kg) using twelve DE-PVCs and four GA-PVCs. After six months, the animals were euthanized, and the explanted PVCs underwent macroscopic and microscopic examination. Results: Large calcium deposits formed along conduit joining suture (CJS) lines in all PVCs, regardless of the cross-linking agent. Mineral clusters surrounded the multifilament braided thread, and its fibers were encrusted with hydroxyapatite crystals. In DE-PVCs, no mineralization occurred outside the suture lines, and they showed successful integration and graft vitalization with a uniform neointima and well-developed endothelial monolayer. GA-PVCs developed a rigid external capsule, foci of collagen fiber calcification within the walls, and neointimal hyperplasia with limited endothelial coverage. Conclusions: In PVCs, calcification predominantly occurs along the CJS lines, where the multifilament suture acts as a nucleation site for hydroxyapatite crystals. DE treatment prevents collagen mineralization, unlike GA, and offers better integration, reduced neointimal hyperplasia, and a well-developed endothelial layer. These findings suggest that DE-PVCs may be a superior option for pediatric cardiac surgery by reducing calcification and improving conduit durability. Overall, the results will help optimize PVC manufacturing strategies to lower the risk of conduit failure.
No takes yet. Share an insight, caveat, or question.
Nichay et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: